Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) General Information

Description

Assets related to insulin resistance and related syndromes, including obesity in Chatham, New Jersey.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 26 Main Street
  • Suite 101
  • Chatham, NJ 07928
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • 26 Main Street
  • Suite 101
  • Chatham, NJ 07928
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)‘s full profile, request access.

Request a free trial

Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Patents

Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019199704-A1 Oxytocin compositions and methods of use Inactive 09-Apr-2018

Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)‘s full profile, request access.

Request a free trial

Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) FAQs

  • Where is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) headquartered?

    Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is headquartered in Chatham, NJ.

  • What industry is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) in?

    Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)’s primary industry is Buildings and Property.

  • Is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) a private or public company?

    Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is a Private company.

  • What is the current valuation of Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)?

    The current valuation of Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is .

  • What is Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)’s current revenue?

    The current revenue for Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) is .

  • Who are Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)’s investors?

    Katana Pharmaceuticals has invested in Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey).

  • When was Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) acquired?

    Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) was acquired on 22-Dec-2020.

  • Who acquired Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey)?

    Katana Pharmaceuticals (Assets Related To Insulin Resistance in Chatham, New Jersey) was acquired by Tonix Pharmaceuticals Holding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process